학술논문
Phase I trial of intratumoral injection of CCL21 gene–modified dendritic cells in lung cancer elicits tumor-specific immune responses and CD8+ T-cell infiltration
Document Type
Article
Author
Lee, J.M.; Lee, M.-H.; Wang, G.; Rosen, F.; Yanagawa, J.; Walser, T.C.; Lin, Y.; Park, S.J.; Tumeh, P.C.; Lee, G.; Elashoff, D.A.; Sharma, S.; Dubinett, S.M.; Garon, E.; Goldman, J.W.; Salehi-Rad, R.; Baratelli, F.E.; Schaue, D.; Abtin, F.; Suh, R.; Adams, S.; Marincola, F.M.; Reckamp, K.L.; Wallace, W.D.; Lee, S.; Zeng, G.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 August 2017, 23(16):4556-4568)
Subject
Language
English
ISSN
15573265
10780432
10780432